Kingworld Medicines Group Limited (HKG:1110)
Hong Kong
· Delayed Price · Currency is HKD 0.500
0.00 (0.00%)
Mar 10, 2026, 2:05 PM HKT
Kingworld Medicines Group Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 295 | 270 | 392 | 529 | 473 | 467 | Upgrade
|
| Market Cap Growth | 15.59% | -31.19% | -25.88% | 11.84% | 1.33% | -14.77% | Upgrade
|
| Enterprise Value | 582 | 465 | 522 | 655 | 601 | 686 | Upgrade
|
| Last Close Price | 0.50 | 0.43 | 0.56 | 0.74 | 0.62 | 0.61 | Upgrade
|
| PE Ratio | 47.72 | 6.10 | 9.34 | 20.58 | 12.71 | 33.56 | Upgrade
|
| Forward PE | - | 9.16 | 9.16 | 9.16 | 9.16 | 9.16 | Upgrade
|
| PS Ratio | 0.29 | 0.24 | 0.33 | 0.49 | 0.46 | 0.53 | Upgrade
|
| PB Ratio | 0.38 | 0.36 | 0.51 | 0.67 | 0.54 | 0.58 | Upgrade
|
| P/TBV Ratio | 0.51 | 0.46 | 0.67 | 0.89 | 0.75 | 0.83 | Upgrade
|
| P/FCF Ratio | - | 2.68 | - | 5.03 | 16.85 | 3.46 | Upgrade
|
| P/OCF Ratio | - | 1.87 | 8.42 | 2.51 | 4.75 | 3.18 | Upgrade
|
| EV/Sales Ratio | 0.57 | 0.41 | 0.44 | 0.61 | 0.58 | 0.78 | Upgrade
|
| EV/EBITDA Ratio | 6.06 | 4.18 | 5.35 | 5.39 | 5.08 | 6.41 | Upgrade
|
| EV/EBIT Ratio | 8.12 | 4.69 | 6.02 | 7.21 | 6.87 | 8.77 | Upgrade
|
| EV/FCF Ratio | -8.47 | 4.61 | - | 6.22 | 21.40 | 5.08 | Upgrade
|
| Debt / Equity Ratio | 0.62 | 0.57 | 0.51 | 0.42 | 0.33 | 0.45 | Upgrade
|
| Debt / EBITDA Ratio | 6.26 | 3.55 | 3.59 | 2.45 | 2.25 | 3.05 | Upgrade
|
| Debt / FCF Ratio | - | 4.25 | - | 3.12 | 10.44 | 2.69 | Upgrade
|
| Net Debt / Equity Ratio | 0.26 | 0.22 | 0.23 | 0.05 | 0.06 | 0.07 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.95 | 1.46 | 1.81 | 0.32 | 0.42 | 0.49 | Upgrade
|
| Net Debt / FCF Ratio | -2.86 | 1.61 | -2.54 | 0.37 | 1.77 | 0.39 | Upgrade
|
| Asset Turnover | 0.65 | 0.77 | 0.83 | 0.77 | 0.69 | 0.59 | Upgrade
|
| Inventory Turnover | 6.10 | 6.65 | 7.89 | 7.10 | 4.93 | 2.78 | Upgrade
|
| Quick Ratio | 0.87 | 0.87 | 0.92 | 0.90 | 1.00 | 1.00 | Upgrade
|
| Current Ratio | 1.14 | 1.18 | 1.27 | 1.15 | 1.35 | 1.29 | Upgrade
|
| Return on Equity (ROE) | 5.53% | 10.60% | 8.84% | 6.16% | 7.32% | 7.53% | Upgrade
|
| Return on Assets (ROA) | 2.02% | 4.23% | 3.78% | 4.05% | 3.61% | 3.25% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.01% | 8.45% | 6.50% | 6.95% | 7.08% | 6.31% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.30% | 10.30% | 9.00% | 11.10% | 9.60% | 9.40% | Upgrade
|
| Earnings Yield | 2.02% | 16.39% | 10.70% | 4.86% | 7.87% | 2.98% | Upgrade
|
| FCF Yield | -23.32% | 37.36% | -17.77% | 19.88% | 5.94% | 28.91% | Upgrade
|
| Dividend Yield | 6.34% | 7.36% | 6.02% | 3.35% | 3.84% | 1.07% | Upgrade
|
| Payout Ratio | 364.34% | 47.60% | 36.54% | 58.45% | 10.89% | 104.76% | Upgrade
|
| Buyback Yield / Dilution | 3.99% | 2.66% | 2.49% | -0.04% | 1.29% | 1.00% | Upgrade
|
| Total Shareholder Return | 10.33% | 10.02% | 8.51% | 3.32% | 5.12% | 2.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.